Literature DB >> 7224128

Spinal analgesia using bupivacaine 0.5% plain. Variation in the extent of the block with patient age.

A E Cameron, R W Arnold, M W Ghorisa, V Jamieson.   

Abstract

Bupivacaine 0.5% plain solution was used to produce spinal analgesia on 63 occasions. In 33 patients a fixed dose of 4 ml injected at the L2/3 interspace at 0.5 ml/second produced an extent of analgesia which was directly related to patient age (p les than 0.005). The latency was 17.3 minutes (SD 8 . 4) and duration of action was 286 minutes (SD 62). A second group receiving only 1 ml of solution had a much shorter duration of action (mean 154 minutes, SD 30). In 90% of patients the analgesia obtained was fully sufficient for surgery to be performed and no form of analgesic supplementation was given. On two occasions no analgesia occurred at all. Bupivacaine 0.5% plain proved to be an effective agent for subarachnoid block. The extent of analgesia was, however, poorly predictable, and even with low doses unacceptably high level of block were sometimes achieved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7224128     DOI: 10.1111/j.1365-2044.1981.tb10211.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  12 in total

1.  Spinal anaesthesia with lidocaine 2% for caesarean section.

Authors:  A Kumar; I Bala; I Bhukal; H Singh
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

2.  The intrathecal spread of hyperbaric dibucaine in adolescents.

Authors:  Y Hirabayashi; R Shimizu
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

3.  The effect of injection speed on the spinal block characteristics of hyperbaric bupivacaine 0.5% in the elderly.

Authors:  Smita Prakash; Veena Bhartiya; Vedatrayee Pramanik; Jyoti Pahilajani; Anoop Raj Gogia; Rajvir Singh
Journal:  J Anesth       Date:  2010-10-26       Impact factor: 2.078

4.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 5.  Spinal anaesthesia.

Authors:  J A Wildsmith
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

6.  Plain bupivacaine 0.5%: a preliminary evaluation as a spinal anaesthetic agent.

Authors:  D W Ryan; A K Pridie; P F Copeland
Journal:  Ann R Coll Surg Engl       Date:  1983-01       Impact factor: 1.891

7.  Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia.

Authors:  Zoubir Djerada; Catherine Feliu; Yoann Cazaubon; Faouzi Smati; Philippe Gomis; Dominique Guerrot; Beny Charbit; Olivier Fernandes; Jean-Marc Malinovsky
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 8.  The epidural test dose in obstetrics: is it necessary?

Authors:  S L Dain; S H Rolbin; E M Hew
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

Review 9.  Clinical pharmacokinetics of epidural and spinal anaesthesia.

Authors:  A G Burm
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

10.  Effect of position changes after spinal anesthesia with low-dose bupivacaine in elderly patients: sensory block characteristics and hemodynamic changes.

Authors:  Hye Young Kim; Myeong Jong Lee; Mi-Na Kim; Ji-Sub Kim; Won Sang Lee; Kyu Chang Lee
Journal:  Korean J Anesthesiol       Date:  2013-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.